3Vezmar S, Becker A, Bode U, et al. Biochemical and clinical aspects of methotrexate neurotoxicity[J]. Chemotherapy,2003, 49(1/2) :92-104.
4Wunderlich MT, Ebert AD, Kratz T, et al. Early neurobe havioral outcome aftor smoke is related to release of neurobiochcmical markers of brain damage[J]. Stroke, 1999,30 (6):1190.
5Herrmann M,Jost S,Kutz S,et at. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomogryaphy[J]. J Neurotrauna, 2000, 17(2) : 113-122.
8Hashimoto H,Kubota M, Shimizu T, et al. Effect of high-dose methotrexate on plasma hypoxanthine and uridine levels in patients with acute leukemia or non-Hodgkin lymphoma in childhood[J]. Leukemia,1992,6(11) :1199-1202.
9Odoul F, Le Guellec C, Lamagnere JP, et al. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukemia using a population pharmacokinetic approach[J]. Fundam Clin Pharmacol, 1999, 13(5) :595-604.
4Missler U,Wiesmann M,Friedrich C,et al.S100 protein and neuron specific enolase comcentrations in blood as indicator of infarction volume and prognosis in acute ischemie stroke.Stroke 1997;28(10):1956-60
5Wijnberger LD,Nikkels PG,van Dongen AJ,et al.Expression in the placenta of neuronal markers for perinatal brain damage.Pediatr Res 2002;51(4):492-6
6Gazzolo D,Marinoni E,Dilorio R,et al.Urinary S100B protein measurements:A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants.Crit Care Med 2004;32(1):134-6
7Rothermundt M,Peters M,Prehn JH,et al.S100B in brain damge and neurodegeneration.Microsc Res Tech 2003;60(6):614-32
8Schulpis KH,Kariyannis C,Papassotiriou I.Serum levels of neural protein S100B in phenylketonuria.Clin Biochem 2004;37(1):76-9
9Marquardt G,Setzer M,Seifert V.Protein s-100b for individual prediction of functional outcome in spinal epidural empyema.Spine 2004;29(1):59-62
10Dietrich DE,Hauser U,Peters M,et al.Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression.Neurosci Lett 2004;354(1):69-73
